Pravastatin

I removed “Pravastatin (Nantes University Hospital – France)” from the phase 2 list because the study is complete (http://www.clinicaltrials.gov/ct/show/NCT00200655) and I can find no evidence of additional studies planned or ongoing.

According to the US MS Society’s clinical trials list, the trial was at least somewhat successful, with an 85% reduction in lesions at month 6 for the pravastatin group compared with a 44% reduction in the placebo group.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: